DNAJB9 and cystic fibrosis: As expected, overexpression DNAJB9 upregulated CFTR ubiquitination (Fig. S4); taken together, these results indicated that DNAJB9 is a functional component of the ERAD of CFTR and suggested that the DNAJB9-dependent ERAD pathway is a novel target for CF therapy.